5 - Biomarkers

Speaker(s)

• 

  Ann Falsey, MD

  Professor of Medicine
  University of Rochester, School of Medicine
  Rochester, New York

  Disclosure: Janssen : Advisor or Review Panel member (Status: Ongoing), Grant/Research Support (Status: Ongoing); Merck, Sharpe and Dohme : Grant/Research Support (Status: Ongoing); Novavax : DSMB (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Pfizer : Advisor or Review Panel member (Status: Ongoing), Grant/Research Support (Status: Ongoing)
• 

  Nathan Ledeboer, PhD

  Professor and Vice Chair of Pathology/Medical Director, Clinical Microbiology
  Department of Pathology
  Medical College of Wisconsin
  Milwaukee, Wisconsin

  Disclosure: bioMerieux : Grant/Research Support (Status: Ongoing); CosmosID : Board Member (Status: Ongoing); Cytovale : Advisor or Review Panel member (Status: Ongoing), Shareholder (Status: Ongoing); Inflammatix : Advisor or Review Panel member (Status: Ongoing), Shareholder (Status: Ongoing); Roche : Consultant (Status: Terminated --- 06/2019); ThermoFisher Scientific : Consultant (Status: Ongoing), Grant/Research Support (Status: Ongoing)
• 

  Octavio Ramilo, MD

  Chief, Division of Pediatric Infectious Diseases; Professor
  Pediatrics
  Nationwide Children's Hospital
  Columbus, Ohio

  Disclosure: Bill & Melinda Gates Foundation : Grant/Research Support; Janssen : Advisor or Review Panel member, Grant/Research Support; Medimmune : Grant/Research Support; Merck : Advisor or Review Panel member (Status: Ongoing); NIH/NIAID : Grant/Research Support; Pfizer : Advisor or Review Panel member, Consultant; Sanofi/Medimmune : Advisor or Review Panel member, Consultant

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE Credits

Learning Objectives:

• describe the most common pathogens identified in febrile infants and their corresponding biomarkers
• to discuss the diagnostic potential of measuring the host response in diagnosing respiratory infections
• describe the novel approaches to detection of host response to predict the risk of sepsis

Presentations:

• 11:00am – 12:15pm EDT

  Distinguishing Viral from Bacterial Infections
  Ann Falsey, MD – University of Rochester, School of Medicine
• 11:00am – 12:15pm EDT

  Host Response Biosignatures in the Febrile Infant
  Octavio Ramilo, MD – Nationwide Children's Hospital
• 11:00am – 12:15pm EDT

  On the Precipice of Transformational Change: Will Novel Approaches to Detection of Host Response Truly Improve the Diagnosis of Sepsis?
  Nathan A. Ledeboer, PhD – Medical College of Wisconsin